Ligand binding affinity and changes in the lateral diffusion of receptor for advanced glycation endproducts (RAGE)

Copyright © 2016. Published by Elsevier B.V..

The effect of ligand on the lateral diffusion of receptor for advanced glycation endproducts (RAGE), a receptor involved in numerous pathological conditions, remains unknown. Single particle tracking experiments that use quantum dots specifically bound to hemagglutinin (HA)-tagged RAGE (HA-RAGE) are reported to elucidate the effect of ligand binding on HA-RAGE diffusion in GM07373 cell membranes. The ligand used in these studies is methylglyoxal modified-bovine serum albumin (MGO-BSA) containing advanced glycation end products modifications. The binding affinity between soluble RAGE and MGO-BSA increases by 1.8 to 9.7-fold as the percent primary amine modification increases from 24 to 74% and with increasing negative charge on the MGO-BSA. Ligand incubation affects the HA-RAGE diffusion coefficient, the radius of confinement, and duration of confinement. There is, however, no correlation between MGO-BSA ligand binding affinity with soluble RAGE and the extent of the changes in HA-RAGE lateral diffusion. The ligand induced changes to HA-RAGE lateral diffusion do not occur when cholesterol is depleted from the cell membrane, indicating the mechanism for ligand-induced changes to HA-RAGE diffusion is cholesterol dependent. The results presented here serve as a first step in unraveling how ligand influences RAGE lateral diffusion.

Medienart:

E-Artikel

Erscheinungsjahr:

2016

Erschienen:

2016

Enthalten in:

Zur Gesamtaufnahme - volume:1858

Enthalten in:

Biochimica et biophysica acta - 1858(2016), 12 vom: 25. Dez., Seite 3141-3149

Sprache:

Englisch

Beteiligte Personen:

Syed, Aleem [VerfasserIn]
Zhu, Qiaochu [VerfasserIn]
Smith, Emily A [VerfasserIn]

Links:

Volltext

Themen:

27432CM55Q
Cholesterol depletion
EC 2.7.11.24
Extracellular Signal-Regulated MAP Kinases
Fluorescence microscopy
Journal Article
Ligands
Membrane biophysics
Receptor for Advanced Glycation End Products
Receptor signaling
Research Support, U.S. Gov't, Non-P.H.S.
Serum Albumin, Bovine
Single particle tracking

Anmerkungen:

Date Completed 26.10.2017

Date Revised 29.04.2018

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.bbamem.2016.10.001

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM265143357